Riskpilot← Back to searchSign inGet full accessHELSETERAPI AS
ASActiveOrg 989643150Granheia 4, 4847 ArendalWholesale of other food · NACE 4638Est. 20061 employees
Revenue 2024
NOK 74K
-52% vs 2023
EBITDA margin
-89.7%
-34% vs 2023
Equity ratio
-1148.6%
Financial strength
Net profit 2024
NOK -85K
-42% vs 2023
| Revenue | NOK 74K | -52% |
| EBITDA | NOK -66K | -34% |
| Net profit | NOK -85K | -42% |
| Total assets | NOK 89K | +47% |
| Equity | NOK -1M | -9% |
| Employees | 1 | — |
Legal name
HELSETERAPI AS
Org number
989643150
Legal form
Aksjeselskap
NACE code
4638 · Wholesale of other food
Founded
25. mars 2006
Share capital
NOK 470 900
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og nestleder hver for seg.
Company purpose
Salg og produksjon av helseprodukter samt eiendomsutvikling.
Address
Granheia 4, 4847 Arendal
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 435 | 286 | 158 | 253 | 134 | 251 | 172 | 223 | 118 | 359 | 115 | 155 | 74 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −46 | −92 | −31 | −37 | −59 | −58 | −51 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 16 | −434 | −501 | −142 | −31 | 100 | 14 | −508 | −17 | 188 | −72 | −50 | −66 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −8 |
| EBIT | 0 | 0 | 0 | 0 | 0 | 16 | −434 | −501 | −142 | −31 | 100 | 14 | −508 | −17 | 188 | −72 | −50 | −74 |
| Net financials | 0 | 0 | 0 | 0 | 0 | −70 | −105 | −117 | −92 | −87 | −78 | −75 | −30 | −38 | −15 | −9 | −10 | −11 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | −54 | −539 | −618 | −233 | −118 | 23 | −61 | −539 | −55 | 172 | −82 | −60 | −85 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | 0 | 0 | 0 | 0 | −54 | −539 | −618 | −233 | −118 | 23 | −61 | −539 | −55 | 172 | −82 | −60 | −85 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | — | — | — | — | 1 091 | 1 779 | 1 986 | 2 143 | 2 072 | 2 071 | 2 070 | 512 | 851 | 155 | 83 | 61 | 89 |
| Equity | — | — | — | — | — | −289 | −491 | −989 | −1 222 | −1 340 | −1 318 | −1 378 | −1 917 | −1 972 | −1 800 | −882 | −942 | −1 027 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 239 | 1 221 | 1 204 | 1 175 | 0 | 550 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 1 380 | 2 269 | 2 976 | 2 127 | 2 191 | 2 185 | 2 273 | 2 429 | 2 274 | 1 955 | 964 | 1 002 | 1 116 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 1 380 | 2 269 | 2 976 | 3 366 | 3 412 | 3 389 | 3 448 | 2 429 | 2 824 | 1 955 | 964 | 1 002 | 1 116 |
EBITDA margin
-89.7%
This company
15.8%
Market median
-668% vs market
20072024
Equity ratio
-1148.6%
This company
38.2%
Market median
-3107% vs market
20072024
Return on equity
-8515700.0%
This company
18.4%
Market median
-46281078% vs market
20072024
Net profit margin
-115.2%
This company
8.1%
Market median
-1522% vs market
20072024
Asset turnover
0.83×
This company
1.12×
Market median
+26% vs market
20072024
Debt / equity
1.09×
This company
0.62×
Market median
-76% vs market
20072024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2017 | — | — | |
| Board of Directors | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 10.7% | 10.7% | 2022 | |
Mercy Wings Holding Sa | Company | 2.4% | 2.4% | 2022 |
| Individual | 2.2% | 2.2% | 2022 | |
| Individual | 1.1% | 1.1% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HELSETERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Glenn Ager-Wick | Chairman | 0 companies |
| Tor Ager-Wick | Board of Directors | 0 companies |